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Abstract
B ackground: There is limited knowledge on the extent and dynamics of the mucosal response to  
commensal and probiotic species in the human intestinal lumen. This study aimed to  identify the 
acute, time-dependent responses of intestinal mucosa to commensal Lactobacillus plantarum  
WCFS1 in vivo in tw o placebo-controlled human intervention studies in healthy volunteers. 
Transcriptional changes in duodenal mucosa upon continuous intraduodenal infusion of L. plantarum  
WCFS1 for one- and six h, respectively, were studied using oro- and nasogastric intubations with 
dedicated orogastric catheters and tissue sampling by standard flexible gastroduodenoscopy.
Results: One- and six-h exposure of small intestinal mucosa to  L. plantarum  WCFS1 induced 
differential expression of 669 and 424 gene reporters, respectively. W hile short-term exposure to  
L. plantarum  WCFS1 inhibited fatty acid metabolism and cell cycle progression, cells switched to a 
more proliferative phase after prolonged exposure with an overall expression profile characterized 
by upregulation of genes involved in lipid metabolism, cellular growth and development. Cell death 
and immune responses w ere triggered, but cell death-executing genes o r inflammatory signals were  
not expressed. Proteome analysis showed differential expression of several proteins. Only the 
microsomal protein 'microsomal triglyceride transfer protein' was regulated on both the 
transcriptional and the protein level in all subjects.
C onclus ion : Overall, this study showed that intestinal exposure to  L. plantarum  W CFS1 induced 
consistent, time-dependent transcriptional responses in healthy intestinal mucosa. This extensive 
exploration of the human response to  L. plantarum  WCFS1 could eventually provide molecular 
support for specific o r probiotic activity of this strain o r species, and exemplifies the strength of 
the applied technology to  identify the potential bio-activity of microbes in the human intestine.
Open Access
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Background
Many lactic acid bacteria (LAB) have a long history of use 
in the preservation of food ingredients [1]. In addition to 
their preservative effect, which is largely based on their 
effectiveness to convert the available carbon sources in the 
raw materials to lactic and acetic acid, LAB-fermentation 
generates many other relevant product characteristics like 
texture, flavor and stability. Various LAB species, given as 
food supplements, exert beneficial bioactivity in the intes­
tine [2,3].
The study of interactions between the hum an host and 
microbes that confer a health promoting effect is mostly 
limited to an evaluation of the effects of the microbes on 
gastrointestinal or systemic symptom scores. Several stud­
ies described beneficial effects of dietary supplementation 
with various LAB, including specific strains of the species 
Lactobacillus plantarum on symptoms in patients suffering 
from irritable bowel syndrome (IBS) [4], in inflammatory 
bowel disease (IBD) patients [5], and on the intestinal 
barrier function in stressed conditions [6]. Detailed, 
descriptive studies of the hum an mucosal response to LAB 
are scarce. DiCaro et al. investigated the effects of L. rham- 
nosus GG on transcriptional responses of small intestinal 
mucosa in oesophagitis patients [7], delivering a myriad 
of information about the impact of a probiotic supple­
mentation regimen on the hum an mucosal response to 
probiotics in a limited number (n = 3) of subjects suffer­
ing from an underlying medical condition.
The present study aimed to identify the response of 
healthy intestinal mucosa upon exposure to L. plantarum 
WCFS1, a single colony isolate from NCIMB8826 
(National Collection of Industrial and Marine Bacteria, 
Aberdeen, UK). This strain was originally isolated from 
hum an saliva and is used as a model microbe in the study 
of host-microbe interactions, due to its established taxon­
omy, its ability to survive gastrointestinal (GI) transit [8] 
and its putative role as a probiotic species [9]. The availa­
bility of the complete genome sequence of L. plantarum 
WCFS1 [10] has strongly facilitated the study of its 
response to the conditions encountered in the mamma­
lian GI tract.
In the present study, we applied a recently developed in 
vivo intestinal perfusion technique [11] to assess the tran­
scriptional and proteomic response of intestinal mucosa 
to short (1 h) and extended (6 h) exposures to L. 
plantarum WCFS1 in healthy subjects. These studies 
focused on the proximal small intestine, because in 
healthy people, only small amounts of microbes reside in 
this intestinal region, whereas it encounters and perceives 
large amounts of food-derived microbes. The fact that 
only small amounts of microbes reside in that specific 
niche enables to determine effects of the L. plantarum
WCFS1 exposures without interference of other mucosa- 
microbe interactions, as would be the case in the distal 
small intestine or the colon, which harbour a large micro­
bial community. This manuscript describes, for the first 
time in healthy subjects, the responses of the intestinal 
mucosa to intraluminal microbes. Biological interpreta­
tion of the gene expression analysis revealed that espe­
cially genes associated with lipid metabolism, cellular 
proliferation, cell death and survival and immune 
responses were modulated. The impact of the microbes on 
transcription of genes involved in these processes is pre­
sented and discussed in detail.
Results
The mucosal responses analyzed and presented here rep­
resent the acute response of epithelial cells interacting 
with L. plantarum cells and their secreted products and 
that of cells from non-interacting, neighboring epithelial 
cells in the lamina propria, which are no t directly exposed 
to luminal contents, and other cell types such as immune 
cells.
Study 1
We observed significant changes in 669 gene reporters; 
225 genes upregulated and 444 gene reporters downregu- 
lated (see Additional file 1). The fold changes of these dif­
ferentially expressed genes ranged from 0.56 to 1.33. A 
fold change of 0.56 means that 56% of the expression of 
the gene in the placebo intervention remains after the L. 
plantarum WCFS1 intervention, whereas a fold change of 
1.33 means that the expression of that gene increased by 
33% due to the L. plantarum WCFS1 exposure.
The biological implications of the altered transcriptional 
profiles were first identified using the pathway analysis 
software suite GenMapp. Table 1 shows the 24 pathways, 
based on the Gene Ontology database, that had a Z-score 
> 3, and 3 gene reporters or more were differentially 
expressed. Among these processes, protein biosynthesis 
and -metabolism, ribosome-associated processes, proc­
esses involved in protease activity and fatty acid oxidation 
seem to be the most important modulated biological 
processes
Study 2
The 6-h L. plantarum challenge significantly modulated 
the expression of 424 gene reporters; 383 were upregu- 
lated and 41 were downregulated (see Additional file 2). 
The fold changes of these differentially expressed genes 
ranged from 0.70 to 1.78. Genmapp pathway analysis 
showed that, based on Gene Ontology databases with the 
criteria set at Z-score > 5, and 3 gene reporters or more dif­
ferentially expressed, 22 pathways were mediated by the 
intervention (Table 2). Processes which are associated 
with the MHC class I and II and other immune response
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Tab le  1: G en M A P P  pathways affected by a 1-h exposure o f duodenal m ucosa to  L. p la n ta ru m  W C FS 1
G O  N a m e Changed M easured T o ta l
caveola 3 4 4
Golgi stack 3 10 12
protein biosynthesis 20 173 252
peptidyl-prolyl cis-trans isomerase activity 6 26 32
protein metabolism 3 13 16
structural constituent o f ribosome 18 153 232
isomerase activity 1 1 77 96
cytosolic large ribosomal subunit (sensu Eukarya) 7 38 39
cytoplasm 35 512 636
ribosome 13 117 167
heterogeneous nuclear ribonucleoprotein complex 4 16 17
translational initiation 3 18 26
endoplasmic reticulum 22 234 271
ER to  Golgi transport 4 18 20
GTPase activity 3 21 38
regulation of translational initiation 4 25 32
fatty acid beta-oxidation 3 12 13
ubiquitin conjugating enzyme activity 7 46 75
chymotrypsin activity 10 79 1 19
catalytic activity 6 96 210
regulation of translation 3 24 27
metabolism 19 243 408
trypsin activity 10 79 134
cytosolic small ribosomal subunit (sensu Eukarya) 5 29 30
Biological processes with relatively high numbers of gene reporters changed, based on the Gene Ontology (GO) database. The table shows the 
process title  (GO name), the number of gene reporters changed changed (changed), measured with the microarrays (measured) and the total number 
of genes present in the pathway MAPP (total) (for detailed description of pathway selection, see Methods).
and antigen processing related processes were modulated 
by the intervention, as well as several processes which are 
involved in energy metabolism (mainly fatty acid beta­
oxidation, tricarboxylic acid cycle and electron transport 
chain).
The proteome analyses of the tissue samples obtained in 
study 2 showed that two proteins differed consistently in 
all volunteers in response to the 6-h exposure to L. 
plantarum (data not shown). One of these spots was iden­
tified as microsomal triglyceride transfer protein (MTP), 
while the analysis failed to allow identification of the sec­
ond spot. The microarray results showed that the expres­
sion of the gene encoding MTP (probeset 205675_at on 
the Affymetrix U113A microarray and indicated by Uni­
Gene reference Hs.195799) was increased by 19.3%, as a 
result of the exposure to L. plantarum. Paradoxically, the 
same gene appeared to be down-regulated by 36.8% in 
the 1 h L. plantarum intervention study, bu t this difference 
did not reach statistical significance. The tissue samples 
from study 1 were not subjected to proteome analyses.
Com parative analysis o f  study 1 and 2
Fifty-four genes were regulated in both the 1 h and 6 h per­
fusion microarray datasets. Of these genes, 4 were differ­
entially expressed in the same direction in both studies (3
were upregulated and 1 downregulated), 2 were upregu- 
lated and downregulated, and 48 were downregulated 
and upregulated in study 1 and 2, respectively. Below, the 
findings of the two studies are compared in detail using 
the Ingenuity Pathways Analysis (IPA) software tool (see 
Availability and requirements section for URL). The statis­
tical assessments of significance of representation of the 
metabolic and signaling pathways that are part of the IPA 
output are based on a right-tailed Fisher's Exact Test. This 
test calculates the probability that genes participate in a 
given pathway, relative to their occurrence in all other 
pathway annotations covered by Ingenuity.
Lipid biosynthesis and fatty acid metabolism 
After 1 h of exposure to L. plantarum, three genes involved 
in lipid and fatty acid metabolism (ACSL5; CD36 antigen, 
and DEGS1) were downregulated (Figure 1). After 6 h 
exposure, the transcription regulators JUND, GTF2I and 
TSC22-D1, which are involved in protection from oxida­
tive stress and lipid/fatty acid metabolism, GPX4, which is 
involved in protection against oxidative stress, the fatty 
acid binding protein FABP1 , the throm bospondin recep­
tor (or fatty acid translocase) CD36, six acyl-CoA genes 
and isocitrate dehydrogenase-1 (IDH1), which is one of the 
more "central" hub proteins were all upregulated. How­
ever, important central regulatory proteins such as the
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Tab le  2: G en M A P P  pathways affected by a 6-h exposure o f duodenal m ucosa to  L. p la n ta ru m  W C FS 1
G O  N a m e Changed M easured T o t
energy pathways 14 83 92
Cytoplasm 26 514 636
oxidoreductase activity 30 318 453
MHC class II receptor activity 5 11 31
tricarboxylic acid cycle 7 22 29
fatty acid beta-oxidation 5 12 13
electron transport 27 221 346
antigen presentation^ exogenous antigen 4 10 30
antigen presentation\, endogenous antigen 4 7 13
antigen processing\, exogenous antigen via MHC class II 4 10 30
antigen processing\, endogenous antigen via MHC class I 4 10 18
endoplasmic reticulum 26 235 271
Mitochondrion 29 365 464
cytochrome-c oxidase activity 5 16 27
Microsome 14 94 118
unspecific monooxygenase activity 6 23 23
lipid metabolism 9 104 129
Glycolysis 8 39 56
Cytosol 12 126 141
mitochondrial membrane 4 10 13
inner membrane 6 26 33
hydrogen ion transporter activity 3 26 33
Biological processes with relatively high numbers of gene reporters changed, based on the Gene Ontology (GO) database. The table shows the 
process title  (GO name), the number of gene reporters changed changed (changed), measured with the microarrays (measured) and the total number 
of genes present in the pathway MAPP (total) (for detailed description of pathway selection, see Methods).
obesity gene leptin or PPAR-y were no t differentially 
expressed after 6 h exposure (Figure 2).
Major transcription factors and proteins mediating cellular 
proliferation
After 1 h exposure to L. plantarum WCFS1, four major 
transcriptional regulators were all found to be downregu- 
lated: the oncogene product MYC (c-Myc), FOS (c-Fos), 
JUN (c-Jun) and the p65 subunit of the NF-kB transcrip­
tion complex, RELA. From these responses, it appears that 
downregulation of genes modulating cellular metabolism 
and proliferation is the central mucosal response to the 
first perception of L. plantarum. None of these regulators 
were differentially expressed after the 6 h exposure.
Cell death and death-inducing factors
Several genes encoding proteins which are involved in reg­
ulation and m odulation of cell death were regulated in 
both studies. The tum or necrosis factor receptors (TNFRs) 
TNFRS1A, which is a major receptor for TNF-a and a 
mediator of apoptosis and regulator of inflammation, and 
TNFRSF4 were downregulated after 1 h infusion of L. 
plantarum, whereas the TNF receptor TNFRSF25 (DR3) 
was upregulated after the 1-h exposure to L. plantarum 
WCFS1. Expression of the TNF-related proteins TNFAIP1 
(B12), which is a membrane-located ion channel and a 
direct target of TNF-induced signaling, transforming growth 
factor alpha (TGF-a), and the TNFR inducer interleukin 1-ß
were downregulated as well after 1 h of exposure to L. 
plantarum WCFS1.
Under cellular immune-response stimulating conditions, 
translocation of the transcription factor NFkB to the 
nucleus promotes the expression of predominantly proin- 
flammatory cytokines. The p65 (RelA) com ponent of NF­
kB was downregulated after 1 h exposure. Expression of 
one of the upstream regulators of NF-kB function, IKBKG 
(IKK-k  or NEMO), was upregulated. IKK phosphorylates 
IkB, thereby targeting IkB for proteolytic degradation and 
indirectly enabling nuclear translocation of NFkB. TNF 
receptor-associated factor 4 (TRAF4), which negatively regu­
lates NF-kB activation upstream from IKK, was also upreg­
ulated after 1 h exposure.
In line with the overall down- or nonregulation of death- 
mediating pathways, one of the non-TNF proteins which 
belong to the group of direct inducers of cell death by 
extracellular signals, the Fas-activated serine/threonine 
kinase FASTK, was downregulated after 1 h exposure to L. 
plantarum.
The genes TPT1 (or histamine releasing factor), cytokine 
induced apoptosis inhibitor 1 (cIAP-1), mitochondrial PUMA 
(BBC3), cathepsin B (CTSB), ATP6V0A1, cathepsin L and 
LAMP2, all of which are associated with cell-death related 
responses, were differentially expressed after the 1 h expo­
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F ig u re  1
C e llu la r  responses a f te r  one h o u r e x p o s u re  to  L  p la n ta ru m .  A fter continuous injection of L. plantarum  WCFS1 for one 
hour into the proximal duodenum, proteins that participate in integrated signalling, metabolic and response pathways were  
modulated in intestinal mucosa. The left area shows genes encoding proteins involved in the regulation of cell death and sur­
vival, the central and right areas shows diverse signalling pathways and proteins that are involved in complement activation 
(immune response; may include genes expressed in immune cells). N ote the involvement of nuclear proteins in modulation of 
cell death and survival.
sure to L. plantarum WCFS1. We found that those genes 
involved in regulation of cell death during acute responses 
were not regulated or expressed after 6 h exposure and 
that no other death-regulating genes were expressed as 
well. O f the TNFR family, only TTRAP, the TRAF and TNF 
receptor-associated protein, was upregulated after 6 h 
exposure to L. plantarum.
Immune responses
After 1 h exposure to L. plantarum, interleukin-1 (IL-1), IL- 
1 receptors IL-1R and IL-1-like receptor IL1RL1 (ST2) were 
downregulated. The pro-inflammatory cytokine receptor 
IL8R1 was downregulated as well. No regulation of these 
genes was found after 6 h exposure.
Several genes activating innate immune responses were 
upregulated after 1 h exposure (Table 3). Among these 
was IF, the gene encoding the complement factor I, a ser­
ine protease which can activate the classical complement 
pathway of innate immune response. A second, CFD
(adipsin) is also a serine protease and activator of the 
complement pathway. C1S, a third serine protease and 
activator of complement pathway is involved in activation 
of G-protein-coupled receptor pathway and contains a 
calcium-binding EGF domain. C1R is a protein similar to 
C1S and is also part of complement pathway. All the 
encoding genes were upregulated after 1-h exposure to L. 
plantarum WCFS1. In line with up regulation of C1S, 
downregulation of one of its inhibitors, SERPINE2, was 
observed.
The C8G gene which encodes the Y polypeptide of com­
plement com ponent 8 was downregulated in the 1 h 
exposure study. C8G is part of the antibacterial Membrane 
Attack Complex (MAC), a cytolytic protein complex 
involved in damaging bacterial cell membranes. Also 
CD93 (C1QR1), a cell-surface glycoprotein and part of 
complement component 1, was downregulated. In con­
trast to 1 h exposure, none of these genes were regulated 
after 6 h exposure.
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F ig u re  2
C e llu la r  responses a f te r  six hours ex p o s u re  to  L  p la n ta ru m .  A fter continuous injection of L. plantarum  WCFS1 for six 
hours into the proximal duodenum, proteins involved in fatty acid metabolism, cell motility and immune responses were mod­
ulated. Genes encoding proteins involved in fatty acid metabolism are in the upper left area of the image, those involved in cell 
motility (may include genes expressed in immune cells) are in the central area, and genes involved in innate and adaptive 
immune response are in the upper right area. Note the modulated ERK/MAPK/MKP-1 signalling pathway that extends into the 
nucleus.
Parts of the MHC class I pathway were found to be regu­
lated after the 1 h exposure. The activating proteasome a  
and ß subunits (PSME1/2) were among the few upregu­
lated genes. The chaperone HSP70 which plays a role dur­
ing processing of cytosolic antigens before uptake into the 
ER, was downregulated. Although no regulation of the 
TAP1 or TAP2 transporters was found, the TAP-binding 
protein (TAPBP) which mediates the interaction between 
de novo produced MHC class I molecules and the trans­
porter associated with antigen processing (TAP), was 
upregulated. Only one of the MHC transmembrane (TM) 
receptors, HLA-DRA was regulated after 1 h exposure. The 
(downregulated) gene product is expressed in antigen- 
presenting cells (APCs) and is involved in immune 
response, exogenous antigen presentation and processing.
After 6 h exposure to L. plantarum WCFS1, the intestinal 
mucosa showed a different immune response-related 
expression profile. Several HLA-type TM receptors belong­
ing to MHC class I and class II were upregulated (Table 3).
The upregulated HLA-A TM receptor is involved in 
immune responses and modulates, upon interaction with 
natural killer (NK) cells, cytotoxicity. The HLA-E gene 
encodes an MHC-class protein with an immunoregula- 
tory function; surface localization of the protein can pro­
tect expressing cells from NK cell-mediated lysis. The 
HLA-DMA TM receptor was among the class II receptors 
that were upregulated after 6 h exposure to L. plantarum 
WCFS1. This receptor is involved in immune response via 
antigen presentation and processing and in the detection 
of microbes. The TM receptor CD74 antigen was also 
upregulated after 6 h exposure. This receptor is involved in 
antigen presentation, immune response and humoral 
defense mechanism, but does also promote cell prolifera­
tion and negative regulation of apoptosis.
Q-PCR The microarray dataset was verified with real-time 
quantitative PCR (QPCR). The observed up- or downreg- 
ulation of eight out of ten genes was confirmed. The Q- 
PCR analysis of two genes, GUCA2A and PCNA, did not
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component function regulation after 1 hr exposure regulation after 6 hrs exposure
IL-1 interleukin-1 cytokine, induction immune responses T -
IL-1R receptor fo r interleukin-1 (IL-1) T -
IF complement factor I, serine protease, activator of complement 
pathway of innate immune response ▲
-
CFD (adipsin) serine protease, activator o f complement pathway of innate 
immune response
▲ -
C1R serine protease, activator o f complement pathway of innate 
immune response and GPCR 1 pathway
▲ -
C1S serine protease, activator o f complement pathway of innate 
immune response and GPCR 1 pathway
▲ -
C8G part o f antibacterial membrane attack complex (MAC) T -
CD74 TM receptor, antigen presentation, immune response and 
humoral defence
▲
CD93 cell-surface glycoprotein, part o f complement component 1, 
activator o f macrophage and cellular adhesion ▼
-
HLA-A * regulation of NK cell cytotoxicity - ▲
HLA-C endogenous antigen presentation - ▲
HLA-E immune response regulation, protection from NK cells - ▲
HLA-G regulatory/suppressive to  T cells, cytokine tolerance - ▲
HLA-DMA antigen presentation, detection of microbes, CLIP release - ▲
HLA-DMB antigen presentation, detection of microbes, CLIP release - ▲
HLA-DPA1 antigen presentation derived from extracellular proteins - ▲
HLA-DRA antigen presentation derived from extracellular proteins ▲ ▲
HLA-DRB1 antigen presentation derived from extracellular proteins ▲
I G-protein coupled receptor
*  HLA (human leukocyte antigen) are transmembrane receptors that are all part of MHC complex pathway, HLA-x are class I, HLA-Dxxx are class
II paralogues.
Green triangles refer to  downregulation, and red triangles to  upregulation of genes related to  immune responses.
confirm the microarray data. In addition, QPCR analysis 
of the gene representing MTP confirmed the microarray 
results.
Discussion
Human in vivo studies aiming to elucidate the interaction 
between microbes and the intestine are hampered by 
medical and ethical limitations. Previously, mainly ani­
mal models have been employed to investigate mucosal 
responses to microbes. In germ-free mice, colonization 
with commensal bacteria induced genes involved in nutri­
ent absorption, mucosal barrier fortification, xenobiotic 
metabolism, angiogenesis and postnatal intestinal m atu­
ration [12], and innate immunity [13]. These studies 
clearly revealed that the exposure to commensal bacteria 
modulates the expression of many genes with diverse 
functions in general gut physiology. It is not clear how 
these findings relate to the hum an in vivo situation, in 
which a complex community of different microbes is 
present. Data on the impact of commensal microbes on 
the transcriptome of hum an gut mucosa in vivo is 
restricted to studies describing the effects of supplementa­
tion of L. GG [7] and of Bacillus clausii [14] on intestinal 
transcriptional responses in oesophagitis patients. In the 
present study, the impact of L. plantarum WCFS1 on gene 
transcription and pathway regulation was investigated in
a hum an in vivo model in healthy volunteers that enabled 
to administer the microbes directly into the small intes­
tine and sample intestinal tissue for transcriptional profil­
ing. To the best of our knowledge this is the first example 
of a study that employs post-genomic technologies to 
unravel specific host-microbe interactions in healthy 
hum an subjects. In two subsequent intervention studies, 
effects of 1- and 6-h continuous injection of L. plantarum 
WCFS1 were investigated. An exposure time of 1-h was 
chosen as the 'short term' exposure time, whereas an expo­
sure time of 6 h was considered as a prolonged exposure. 
Previous studies in our lab showed that after a 6-h period, 
problems may arise due to the long fasting period, during 
which subjects remain at rest and, hence, this was consid­
ered as the maximal time frame for the chosen experimen­
tal set-up.
The two studies presented here showed regulation of sev­
eral hundreds of genes in small intestinal mucosa induced 
by intraluminal ingestion of L. plantarum. Exposure of 
proximal small intestinal mucosa for 1 h to L. plantarum 
provoked a transcriptional response, which at least in part 
appeared to be modified in the prolonged (6 h) exposure. 
The temporal changes in gene transcription during the 
first hours of intraluminal injection of L. plantarum as 
described in this manuscript provides an in-depth over­
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view of the cellular host response to intraluminal non- 
pathogenic microbes. The observed counter-regulatory 
responses are im portant for the maintenance of normal 
gut homeostasis. This was confirmed by the observations 
of the proteomics assay in the prolonged exposure study, 
in which only two proteins were consistently found to be 
differentially present after the L. plantarum exposure com­
pared to placebo. In the acute exposure study, no attempts 
were undertaken to investigate differences in protein pro­
files, because the exposure period of 1 h was expected to 
be too short to provoke substantial differences at the pro­
tein level.
Lipid and fatty acid uptake and metabolism participate in 
a diversity of cellular functions including membrane bio­
genesis, general metabolism and (bacterial) signaling. 
With increasing mucosal exposure time to L. plantarum, 
the transcriptional profile of lipid and fatty acid uptake 
and metabolism was also affected, reflecting an increase 
of fatty acid and lipid metabolism.
After 1 h perfusion, several genes involved in lipid and 
fatty acid metabolism or uptake and transport (ACSL5; 
CD36 antigen and DEGS1) were downregulated, suggest­
ing that the mucosal cells did not actively take up or 
metabolize additional fatty acids and lipids during the 
interaction with L. plantarum in comparison to placebo- 
treated mucosa. In contrast, after the prolonged exposure 
of 6 h, three transcription regulators involved in lipid/ 
fatty acid metabolism and protection from oxidative stress 
as a result of this metabolism (JUND, GTF21 and TSC22- 
D1) were upregulated in comparison to the placebo treat­
m ent (Figure 2). One im portant gene involved in protec­
tion against oxidative stress, glutathione peroxidase 
(GPX4), was also upregulated after 6-h exposure to L. 
plantarum.
The CD36 glycoprotein, which plays a role in cellular 
adhesion and in the regulation of fatty acid transport and 
uptake, and participates in cellular control of oxidative 
stress by binding to oxidized low-density lipoprotein [15], 
was downregulated after 1-h exposure, but was upregu- 
lated after 6 h exposure to L. plantarum. The fatty acid 
binding protein FABP1 was upregulated in the 6-h expo­
sure study, as was the microsomal and ER-localized trig­
lyceride transfer protein, MTP, which is discussed in more 
detail below. Hence, it is clear that the prolonged expo­
sure to L. plantarum induced upregulation of genes 
involved in fatty acid uptake. Several genes participating 
in mitochondrial and peroxisomal fatty acid metabolism 
(e.g. acyl-CoA genes) or membrane sphingolipid metabo­
lism (ASAH1) were upregulated as well (Figure 2).
Microsomal triglyceride transfer protein (MTP) was m od­
ulated on the transcriptional and on the protein level dur­
ing the interaction with L. plantarum in the 6-h exposure 
study. MTP is involved in intracellular lipid transport and 
secretion, and is primarily expressed in liver and intestinal 
tissues [16]. Recently, MTP was also found to be involved 
in modulating the intestinal immune response to antigens 
by regulating type I CD1 molecules [17,18], which are 
major histocompatibility complex (MHC) class I-homo- 
logues. It was also shown that MTP affects antigen presen­
tation and is able to regulate CD 1a, CD 1b and CD 1c 
production, hence supporting the idea that MTP is impor­
tant in the host response to microbial pathogens. This is 
in agreement with the other MHC-related responses 
observed in this study, as described below. Overall, medi­
ation of MTP in response to extra- and intracellular signals 
may affect the mucosal response to pathogens, and may 
also affect lipid metabolism and plasma lipoprotein lev­
els. MTP inhibitors may be used to promote weight loss 
[19], bu t they may have detrimental side effects, such as 
fat accumulation in the liver and small intestine. The 
observation that MTP was non-significantly downregu- 
lated in the 1-h exposure study, whereas it was upregu- 
lated in the extended, 6-h exposure study, presents a 
challenging situation to speculate on the eventual physio­
logical consequences. The role of MTP in lipid metabo­
lism, a process that was affected by L. plantarum, and its 
role in the immune response involving dendritic cells [18] 
could suggest that upon L. plantarum exposure, a mucosal 
response was triggered that initiated microbe sensing by 
dendritic cells, which was at least in part mediated by 
MTP, and stimulated lipid metabolism-related processes 
in intestinal mucosa.
The down-regulation of major transcription factors stimu­
lating cell proliferation observed in the acute exposure 
study suggests that cell proliferation is suppressed after 
the first perception of L. plantarum cells. The initial down- 
regulation of the cellular cycle may be the result of a shift 
in cellular activity towards microbial perception, cell 
defense and immune responses. Indeed, both during 
acute (1 h exposure) and later responses, modulation of 
immune response pathways and cellular death, survival 
and proliferation was observed.
Transforming growth factor-ß (TGF-ß) is an im portant 
regulator of cell proliferation [20]. Although no regula­
tion of TGF-ß was observed in the datasets, the TGF-ß- 
early-response genes TSC22 displayed exposure-time 
dependent differential regulation in time, with downreg- 
ulation after 1 h (TSC-22D1, -3) and upregulation after 6 
h (TSC-22-D1). TSC-22 is an im portant downstream com­
ponent of TGF-ß and PPARy signaling during intestinal 
epithelial cell differentiation. Both TGF-ß and PPARy sig­
naling pathways are important for inhibiting excessive 
epithelial cell proliferation in the intestine [21]. The 
downregulation of proliferation in the acute phase, after
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the 1-hr exposure to L. plantarum, appeared to be further 
enhanced by an upregulation of the proliferation-inhibit­
ing gene product IFITM3. Generally, proliferation rates are 
primarily determined by two main and interacting path­
ways, i.e., the NFkB and the mitogen-activated protein 
(MAP) kinase pathways. After 6 h exposure, the MAP 
kinase ERK1 (MAPK3) was upregulated. In the cellular 
context, ERK1 may have acted as an inhibitor of cellular 
over-proliferation by downregulating important onco­
gene regulators such as c-Fos and by antagonistic effects 
on ERK2 function, a related MAPK, that mediates prolifer­
ative signals [22].
NFkB is one of the key regulators of both cell proliferation 
and apoptosis [23]. Remarkably, after 1 h treatment with 
L. plantarum, only down-regulation of the p65 subunit of 
NFkB was found, while no com ponent of NFkB was dif­
ferentially expressed after 6 h exposure. The exact role of 
NFkB in cell proliferation is not clear, but it was shown 
that NFkB is required for cell proliferation by mediating 
the expression of c-Myc [24], which stimulates the tran­
scription of genes with an im portant role in cell cycle con­
trol, like cyclins, CDKs and E2F [25].
NFkB plays an im portant role in the regulation of apopto- 
sis. It suppresses apoptosis by inducing the expression of 
several anti-apoptotic proteins and by modulating the 
expression or activity of pro-apoptotic proteins [25]. Par­
adoxically, NFkB also exerts pro-apoptotic activity [26]. 
NFkB itself exists as an inactive cytoplasmic complex, 
bound to inhibitory proteins of the IkB family. Upon 
stimulation, TRAFs recruit NFkB -inducible kinases (NIK) 
that phosphorylate the IKK complex that subsequently 
triggers ubiquitination of the IkB, which makes it possible 
for the NFkB complex to translocate from the cytoplasm 
to the nucleus, where it activates transcription of various 
genes [27]. One caspase recruitment domain protein, 
CARD10, induces NFkB activity through interactions with 
the IKK complex [28]. This CARD 10, was upregulated 
after 6 h exposure, suggesting NFkB activity induction. 
However, the simultaneous upregulation of TTRAP, a 
gene that encodes a protein that inhibits NFkB by binding 
to TNF receptors [27 ] may have antagonized the presump­
tive CARD 10 induction of NFkB complex.
Cell death induction during interactions with microbes 
occurs primarily through TLR signaling and expression of 
death-inducing cytokines, such as tumor necrosis factor 
(TNF) or Fas ligand (FasL) with concomitant increased 
expression of the appropriate death-signaling receptors. 
One receptor of the TNF family, TNFRSF25, was upregu­
lated during acute response (1 h exposure). TNFRSF25, 
also called death receptor 3 (DR3), induces NFkB activa­
tion and thereby mediates the activation of apoptosis 
[29].
Although several genes associated with cell death were 
found to be differentially expressed, none of these are 
known to stimulate or execute cell death. Importantly, 
with progressing duration of exposure to the microbes, 
cells did not appear to maintain the cellular "gestation" 
phase with downregulated metabolism that characterized 
the acute 1-h response to L. plantarum but rather, to switch 
to a more proliferative phase with an overall expression 
profile characterized by upregulation of genes involved in 
cellular growth, proliferation and development. Notwith­
standing this shift to cellular proliferation, monitoring of 
bacterial presence was still evident, as can be deduced 
from the upregulated expression of antimicrobial a- 
defensins and the major histocompatibility complex 
(MHC) antigen processing and presentation pathway.
Important MHC and other innate immune system-related 
receptors and effectors were differentially expressed after 1 
and 6 h exposure, respectively. After the 1 h exposure to L. 
plantarum, genes encoding major complement compo­
nent 1 proteins were upregulated, representing a group of 
proteins that mediate the "classical pathway" of the com­
plement immune response. In contrast, the C8G gene, 
which encodes the y polypeptide of complement compo­
nent 8 was downregulated. This gene is part of the anti­
bacterial Membrane Attack Complex (MAC), a cytolytic 
protein complex involved in damaging bacterial cell 
membranes. The observation that this antibacterial pro­
tein was down-regulated might imply that the immune 
system in the intestinal mucosa can perceive L. plantarum 
within 1 h and recognize these as commensal and non- 
pathogenic bacteria.
Prolonged infusion of L. plantarum induced MHC antigen 
processing and presentation pathways indicating that 
mucosal epithelia actively performed a bacterial monitor­
ing and identification process. CD74, one of the major 
receptors, which can be bound by bacteria, was one of the 
upregulated genes. This receptor is involved in antigen 
presentation and immune responses [30], bu t does also 
promote cell proliferation and negative regulation of 
apoptosis.
Several MHC-I and MHC-II transmembrane receptors 
were upregulated after the 6 h exposure. After prolonged 
exposure to lactic acid bacteria, CD74 and HLA-DMA and 
-B were upregulated. These receptors participate in the 
MHCII pathway of antigen endocytosis, processing and 
presentation [31,32]. The increased expression of HLA-E 
indicates that epithelial cells were actively protected from 
potentially damaging immune system responses. Increas­
ing the am ount of HLA-E present at the cell surface 
renders cells less sensitive to natural killer-cell-mediated 
lysis. Stabilization of HLA-E expression is among others
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mediated by HLA-A2 [33] and the expression of this pro­
tein is also upregulated after 6 h.
Summarizing, complement 1 was induced during acute 
responses and MHC antigen processing and presentation 
pathways were being expressed after 6 h exposure, which 
suggests the activation of bacterial monitoring and identi­
fication process. Based on the microarray data, no inflam­
matory immune responses were executed. Rather, the 
expression profile after 6 h of exposure to L. plantarum is 
in agreement with cellular proliferation. However, it 
should be noted that after 6 h perfusion, the Paneth-cell- 
specific defensin a5 was upregulated, which indicates that 
the luminal microbes were perceived and their numbers 
controlled by immune responses from the crypt regions of 
the intestinal mucosa.
The Q-PCR analyses were in agreement with the micro­
array data. The gene expression results of eight out of ten 
genes were confirmed, which is in line with the consensus 
that the Affymetrix microarray platform provides a relia­
ble platform to measure gene expression [34]. The 
observed differences between these two technologies are 
in line with the observations of others [34], and are 
mostly caused by differences in probe sequence and thus 
target location.
The present manuscript provides an in-depth overview of 
the initial transcriptional response of healthy intestinal 
mucosa upon its interaction with live bacterial cells of L. 
plantarum, describing time-dependent changes in tran­
scriptional responses after 1 and 6 h of bacterial exposure 
to L. plantarum. The observed changes were modest, as 
genes were affected by maximally 78%. This is in concord­
ance with the impact of an intervention study by our 
group in humans, in which also only modest impacts on 
fold changes, up to doubling of the gene transcripts, was 
observed [11]. The biological observations of the present 
study were in line with those observed in previous studies 
on the effects of a 30-d supplementation with the probi­
otic microorganisms L. rhamnosus GG and of Bacillus 
clausii on transcriptional responses of small intestinal 
mucosa in humans [7,14]. Immune modulation, cell 
growth, and cell-cell signaling were mediated at the tran- 
scriptome level by all three microbes (B. clausii, L. rham- 
nosus GG and L. plantarum WCFS1). In addition, our study 
revealed that L. plantarum WCFS1 mediates fatty acid 
uptake- and metabolism, contributing not only to lipid 
metabolism but also to immune response m odulation as 
discussed above. It should be noted that, although the 
authors of the 30-d supplementation studies state that 
effects of probiotics on healthy duodenum were investi­
gated, the use of medication (proton pum p inhibitors) as 
well as the small sample size (n = 3 in each group) hamper 
the generalization of their results and, hence, comparison
with the results of the present study may not be justified. 
We would like to emphasize that the effects on gene tran­
scription, observed in the present study, may no t be spe­
cific for L. plantarum WCFS1. As indicated above, some 
biological effects were also induced by other microbes. 
Future studies should reveal whether L. plantarum WCFS1 
induces specific and unique responses in the gastrointesti­
nal tract.
In conclusion, the present study showed that L. plantarum 
WCFS1 induced time-dependent transcriptional changes 
in intestinal mucosa in healthy subjects. Among a variety 
of biological processes, especially lipid metabolism, cellu­
lar proliferation, cell death and survival and immune 
responses were modulated. The gene expression profiles 
suggest that cell death and pro-inflammatory responses 
were triggered, but not executed. This extensive explora­
tion of the hum an response to L. plantarum WCFS1 may 
eventually provide molecular support for specific or pro­
biotic activity of this strain and/or species, and exempli­
fies the strength of the applied technology for the 
identification of the potential bio-activity of microbes in 
the hum an intestine.
Methods
This study encompassed two hum an intervention studies, 
which are described below under 'study 1' and 'study 2', 
respectively. Both studies were approved by the University 
Hospital Maastricht Ethical Committee, and conducted in 
full accordance with the principles of the 'Declaration of 
Helsinki' (52nd WMA General Assembly, Edinburgh, Scot­
land, Oct 2000). All subjects gave their written informed 
consent prior to their inclusion into the study.
Preparation o f  L. p lantarum  W CFS1
L. plantarum WCFS1 was grown on MRS medium under 
anaerobic conditions, following standard laboratory pro­
cedures. Fifteen minutes prior to each experiment with L. 
plantarum WCFS1, 1011 freshly prepared L. plantarum 
WCFS1 were resuspended in 600 mL physiological saline 
solution, containing 10 g/L glucose, at 37°C.
Study 1 
Subjects
Eight healthy non-smoking volunteers (24 ± 4 y) without 
a history of GI symptoms and free of any medication, 
were investigated on two separate occasions in a rand­
omized placebo-controlled crossover study.
Protocol
After an overnight fast, mucosal tissue samples were 
obtained from the horizontal part of the duodenum, 
approximately 15 cm distal to the pylorus, by standard 
flexible gastroduodenoscopy and a perfusion catheter was 
placed orogastrically in the proximal small intestine, as
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described previously [11]. Briefly, a catheter that enabled 
to inject a fluid 5 cm distal to the pylorus was inserted dur­
ing a gastroduodenoscopy procedure. Catheter position­
ing was performed under short interval fluoroscopic 
control. No sedatives were given to the volunteers. Subse­
quently, during the first 180 m in of the experiment, a 
physiological saline solution containing 10 g/L glucose 
was infused continuously at 10 m l/m in using a peristaltic 
pump. After this period, which allowed establishment of 
steady state conditions in intestinal fluid fluxes, physio­
logical saline containing 10 g/L glucose with or without, 
in total, 1 X 1011 L. plantarum WCFS1 was infused for one 
hour. Fluids were maintained at 37 °C using a shaking 
water bath. Subjects remained in the supine position until 
the end of the experiment, and food or beverage con­
sumption was not allowed during the experiment. After 
the perfusion experiment, the perfusion catheter was 
removed by gently pulling out the catheter. A second gas- 
troduodenoscopy was performed exactly 15 minutes after 
the perfusion experiment to obtain tissue samples from 
the same intestinal region as earlier that day. The entire 
protocol was repeated on another day, 13 to 16 days after 
the first experiment, to randomly investigate the effects of 
placebo or L. plantarum WCFS1. In all tissue samples, gene 
expression levels were measured using genome-wide 
microarrays (Affymetrix U133A; see below). No samples 
were taken for proteome analysis purposes, because 
changes at the protein level were not expected to occur 
within the 1-h exposure time to L. plantarum WCFS1.
Study 2 
Subjects
Seven healthy non-smoking volunteers (28 ± 6 y), with­
out a history of gastrointestinal complaints and free of any 
medication, participated in a randomized placebo-con­
trolled crossover study.
Protocol
After an overnight fast, an intraduodenal feeding catheter 
(naso-intestinal tube, Flocare® Bengmark, Nutricia Health­
care S.A., Chatel-St. Denis, Switzerland) was placed 
nasogastrically following the manufacturers instructions. 
No sedatives were given to the volunteers. After position­
ing of the catheter in the small intestine (tube tip posi­
tioned 5-10 cm distal to the pylorus), a physiological 
saline solution containing 10 g/L glucose and a total of 
1012 L. plantarum WCFS1 or, randomly on another test 
day, only physiological saline solution containing 10 g/L 
glucose, was injected continuously at 6.7 m l/m in for 6 h. 
The concentration of bacteria present in the fluid was the 
same in both studies, which was important in order to 
allow proper comparisons between the different studies. 
The infusion rate was less than that in study 1, to avoid 
injecting too large amounts of fluid and bacteria, which 
could have induced gastrointestinal symptoms. Fluids
were maintained at 37°C using a shaking water bath. Sub­
jects remained in the supine position until the end of the 
experiment, and food or beverage consumption was not 
allowed during the experiment. After this 6-h period, tis­
sue samples were obtained from the horizontal part of the 
duodenum, approximately 15 cm distal to the pylorus, by 
standard flexible gastroduodenoscopy, at approximately 
15 cm distal to the pylorus. In all tissue samples, gene 
expression levels were measured using genome-wide 
microarrays (Affymetrix U133A; see below). In duplicate 
tissue samples, differential proteome analyses were per­
formed using the CyDIGE m ethod (2D gel-electrophore- 
sis with minimal fluorescent labeling) with Maldi-TOF 
MS (see below).
Microarray analyses
RNA isolation Total RNA was isolated using a TRIzol lysis 
assay. Next, total RNA of each separate tissue sample was 
hybridized onto GeneChip microarrays (HG U133A; 
Affymetrix Inc, Santa Clara, Ca, USA) according to the 
manufacturer's instructions. Hence, for study 1, 32 RNA 
samples were hybridized (tissue samples from 8 subjects, 
obtained before and after the intervention with L. 
plantarum WCFS1 and placebo, respectively) and for study 
2, 14 RNA samples (obtained from 7 subjects, taken after 
to exposure to L. plantarum WCFS1) were hybridized onto 
the chips. Briefly, 1 mL TRIzol (Invitrogen Life Technolo­
gies b.v., Breda, The Netherlands) and 10 |J.L ß-mercap- 
toethanol (VWR International b.v., Amsterdam, The 
Netherlands) were added to each frozen tissue sample and 
shaken with a minibeadbeater for 30 seconds. 200 |J.L 
Chloroform (Sigma Aldrich Chemie b.v., Zwijndrecht, 
The Netherlands) was added and the samples were incu­
bated for 3 minutes, followed by phase separation using 
centrifugation at 21000 g for 15 minutes. The upper aque­
ous phase was taken and 500 |J.L 70% Ethanol was added. 
Subsequently, the extracted RNA was purified using the 
RNeasy Mini Kit (Qiagen Benelux b.v., Venlo, The Nether­
lands) with extra DNA digestion by on-column RNase- 
Free DNase treatment (Qiagen Benelux b.v., Venlo, The 
Netherlands). RNA purity was determined using nano­
drop equipm ent (ND-1000 spectrophotometer, Isogen 
Life Science B.V., IJsselstein, The Netherlands). Only RNA 
samples with a 260/280 ratio between 1.9 and 2.1 were 
considered for further analysis. RNA integrity was deter­
m ined using Bioanalyzer technology (Bioanalyzer 2100, 
Agilent, Santa Clara, USA). RNA samples with RNA integ­
rity numbers (RIN) above 8.0 were considered for further 
analysis.
M icroarrays
Total RNA was hybridized onto GeneChip microarrays 
(Affymetrix Inc, Santa Clara, Ca, USA) according to the 
manufacturers' instructions. For this analysis, five micro­
grams of total RNA from each sample, and the one-cycle
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labeling system were applied as recommended by the 
manufacturer (Affymetrix Inc, Santa Clara, Ca, USA). 
Microarrays were scanned using a GeneChip Instrument 
System (Affymetrix Inc, Santa Clara, Ca, USA). The micro­
array data calculations to obtain detailed information on 
differentially expressed genes are described in the supple­
mentary material (see Additional file 3).
Pathway analysis
The genes analyzed and fold changes were loaded into 
GenMapp [35] and MAPPFinder [36] and into the GOur­
met and Ingenuity Pathway Analysis IPA: (see Availability 
and requirements section for URL) software packages to 
evaluate the transcripts in relation to known biological 
processes, molecular function and cellular component 
based on Gene Ontology (GO) terms and local maps. 
Only gene transcripts with either their average intensities 
for the placebo and treated groups above 500 or average 
intensities for one of these groups above 1000 and a 10 
percent up or down regulation, respectively, were used to 
obtain a ranked list of pathways with differentially 
expressed genes.
MappFinder software was used to select the MAPPs with 
relatively high numbers of differentially expressed genes, 
which were affected by Lactobacillus plantarum WCFS1 
compared to placebo. The ranking of regulated pathways 
was indicated by the individual Z-scores. The Z-score 
increases if higher numbers of changing genes are found, 
taking into account the number of genes present in the 
MAPP that are represented on the array, and the total 
number of genes involved in the concerning MAPP. 
MAPPs were selected for further study if the group results 
(Lacobacillus plantarum WCFS1 compared to placebo) 
reached an arbitrary Z-score of at least 3 on that MAPP for 
study 1 and at least 5 for study 2, and at least 3 genes were 
differentially expressed in that pathway. Different Z-score 
cut-off points were used for the two studies because effects 
in study 2 were more pronounced and revealed regulation 
of more biological pathways, thus allowing the use of a 
more stringent statistical cut-off in the pathway analysis.
Pathw ay visualization
Further refinement and biological interpretation of recon­
structed pathways was performed by comparison with 
published information and pathways available from 
NCBI Entrez Gene info (see Availability and requirements 
section for URL), the Protein, Signaling, Transcriptional 
Interactions & Inflammation Networks Gateway database 
pSTIING, (see Availability and requirements section for 
URL) and BioCarta charts (see Availability and require­
ments section for URL). Based on the combined informa­
tion from IPA and pSTIING and published data, a 
graphical representation of the microarray results in terms 
of their encoded and interacting proteins and pathways
was reconstructed using the image ("toolbox") palette 
provided by Biocarta.
Q-PCR First Strand cDNA was synthesized using the 
iScript cDNA Synthesis kit (Bio-Rad, Veenendaal, The 
Netherlands) according to the manufacturer's instruc­
tions. 250 and 500 ng total RNA was used as template for 
the cDNA reaction of Study 1 en Study 2 respectively. The 
difference in starting quantities was the consequence of 
the smaller am ount of RNA available for study 1, which 
was due to a smaller size of the tissue samples obtained in 
this study. The cDNA was diluted with RNase free H2O to 
a concentration of 5 and 10 ng/|il respectively. IQ Sybr 
Green Supermix (Bio-Rad, The Netherlands) was used for 
the Q-PCR. Each Q-PCR reaction of the Q-PCR contained 
12,5 |il iQ Sybr Green Supermix, 1 |il of 10 |J.M gene-spe­
cific forward and reverse primers, 2 |il cDNA template 
solution and 8,5 |il sterile water. The following primers 
were used. Housekeeping genes were 18SrRNA: gtaacccgtt- 
gaaccccatt, ccatccaatcggtagtagcg; GAPDH: tgcaccaccaact- 
gcttagc, ggcatggactgtggtcatgag and Calnexin: 
ccactgctcctccttcatctcc, cggtatcgtctttcttggctttgg. Genes study 
1; GUCA2A: gggttgggaaactcaggaactttg, tacaggcagcgtag- 
gcacag; PCNA: gccactccactctcttcaacgg, tggtgacagaaaagact- 
tcagtatatgc; CD36: ggaatctgtcctattgggaaagtcactgc, 
ctgggttttcaactggagaggcaaagg; FOS: ctgtgtctcttttctctttctcct- 
tagtc, tccagcaccaggttaattccaataatg; DUSP1: agcagaggcgaag- 
catcatc, acggtggtggtggaggtg. Genes study 2; PLA2G2A: 
gcagaagtcaactgtgtgagtgtg, gggagggagggtatgagagagg;
DEFA6: ggctcaacaagggctttcac, gtatgggacacacgacagtttc; 
CDS1: tggattcattgctgcctatgtgttatc, ctttagaaagggtggaagtgag- 
taagtc; REG3A: gctgtcccaaaggctccaagg, atcacatcactgctactc- 
cactcc; CD 24: gtatttgggaagtgaagactggaagc,
agtgttctaaatgtggctattctgatcc. Gene study 1 and 2; MTP: 
ggacctagcacagaggaatcag, ccaaatccaccagtttcttgaagc. Reac­
tions were run on the My IQ Single Color Real Time PCR 
Detection System (Bio-Rad, Veenendaal, The Nether­
lands). The cycling conditions comprised 3 minutes at 
95°C and 40 cycles at 95°C for 10 seconds and 60°C for 
45 seconds followed by a melting program. The CT values 
were normalized using the IQ5 Optical System Software 
version 2.0 (Bio-Rad, Veenendaal, The Netherlands). 
Gene-transcripts were analyzed using a multivariate Gaus­
sian linear regression, similar to the microarray analysis, 
with the difference of having the sample concentration, 
the test day, the perfusion procedure, repeats, and the best 
housekeeping gene among 18S ribosomal RNA, GAPDH 
and calnexin included. Detailes of the Q-PCR calculations 
are provided in Additional file 3.
Proteomics analysis
Intestinal biopsies were prepared for protein analysis by 
sonication in a lysis buffer, and subjected to the 2-D Clean 
Up kit (Amersham Biosciences, Freiburg, Germany) to 
remove non-protein material. Protein concentrations
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were measured using the 2-D Quant Kit (Amersham Bio­
sciences, Freiburg, Germany). The samples were further 
processed for two-dimensional fluorescence difference gel 
electrophoresis with the Ettan™ DIGE technique, follow­
ing the manufacturers instructions [37]. Protein mixtures 
were separated by 2D electrophoresis, according to their 
iso-electric points, using the Ettan IPGphor 3 isoelectric 
Focusing System, and to their molecular weights using an 
EttanDalt12 electrophoresis system. Samples from the 
placebo intervention and from the L. plantarum interven­
tion were loaded on one IPG-strip, together with a pooled 
internal standard. After the 2D-electrophoresis, the gels 
were scanned with a Typhoon confocal laser scanner 
(Typhoon 9410 Variable Mode Imager, Amersham Bio­
sciences), and the scanned images were loaded into DeCy­
der software (Decyder 2D, Amersham Biosciences, 
Freiburg, Germany) to analyse the differences in protein 
profiles. Differentially expressed protein spots were 
picked with the Ettan Spot picker (Amersham Biosciences, 
Freiburg, Germany). Excised spots were subjected to mass- 
fingerprint identification using Maldi-TOF MS analysis as 
described elsewhere [38].
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